JCRRF (JCR Pharmaceuticals Co) Dividend Payout Ratio: 21.00 (As of Mar. 2026) — 5285% Above Median


JCRRF JCR Pharmaceuticals Co Ltd JCRRF
55 GF Score
Price $3.31
GF Value $5.63
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is JCR Pharmaceuticals Co Dividend Payout Ratio?

JCR Pharmaceuticals Co JCRRF +5.25% 55 Dividend Payout Ratio is 21.00 as of Mar. 2026, which is 5285% above its 10-year median of 0.39. GuruFocus rates JCRRF with a GF Score™ of 55/100 and a GF Value™ of $5.63 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 445 Drug Manufacturers companies, JCR Pharmaceuticals Co ranks worse than 99.55% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. JCR Pharmaceuticals Co's Dividend Payout Ratio for the months ended in Mar. 2026 was 21.00.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of JCR Pharmaceuticals Co Ltd is 4.51, which seems too high.

The historical rank and industry rank for JCR Pharmaceuticals Co's Dividend Payout Ratio or its related term are showing as below:

JCRRF' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.16   Med: 0.39   Max: 5.88
Current: 5.88

During the past 13 years, the highest Dividend Payout Ratio of JCR Pharmaceuticals Co was 5.88. The lowest was 0.16. And the median was 0.39.

JCRRF's Dividend Payout Ratio is ranked worse than
99.55% of 445 companies
in the Drug Manufacturers industry
Industry Median: 0.38 vs JCRRF: 5.88

As of today (2026-07-09), the Dividend Yield % of JCR Pharmaceuticals Co is 3.76%.

During the past 13 years, the highest Trailing Annual Dividend Yield of JCR Pharmaceuticals Co was 4.75%. The lowest was 0.25%. And the median was 0.77%.

JCR Pharmaceuticals Co's Dividends per Share for the months ended in Mar. 2026 was $0.13.

During the past 5 years, the average Dividends Per Share Growth Rate was -1.70% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 18.20% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of JCR Pharmaceuticals Co was 51.30% per year. The lowest was -3.90% per year. And the median was 15.00% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

JCR Pharmaceuticals Co (OTCPK:JCRRF) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

JCR Pharmaceuticals Co Dividend Payout Ratio Related Terms

JCR Pharmaceuticals Co Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for JCR Pharmaceuticals Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JCR Pharmaceuticals Co Dividend Payout Ratio Chart

JCR Pharmaceuticals Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.16 0.66 0.45 0.00 6.75

JCR Pharmaceuticals Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.55 0.00 21.00

JCRRF vs LLY, JNJ, ABBV: Dividend Payout Ratio Comparison

For the Drug Manufacturers - General subindustry, JCR Pharmaceuticals Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JCR Pharmaceuticals Co Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JCR Pharmaceuticals Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where JCR Pharmaceuticals Co's Dividend Payout Ratio falls into.


JCRRF
55GF Score
JCR Pharmaceuticals Co Ltd JCRRF
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JCR Pharmaceuticals Co Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

JCR Pharmaceuticals Co's Dividend Payout Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Mar. 2026 )/ EPS without NRI (A: Mar. 2026 )
=0.189/ 0.028
=6.75

JCR Pharmaceuticals Co's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2026 )/ EPS without NRI (Q: Mar. 2026 )
=0.126/ 0.006
=21.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 21.00 mean?
JCR Pharmaceuticals Co (JCRRF) has a Dividend Payout Ratio of 21.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on JCR Pharmaceuticals Co and its competitors. This is 5285% above median its historical median of 0.39. Over the past decade, JCR Pharmaceuticals Co's Dividend Payout Ratio has ranged from 0.16 to 5.88. According to the industry distribution chart, JCR Pharmaceuticals Co ranks #443 out of 445 companies in the Drug Manufacturers industry, placing it in the top 99.6%.
Is JCR Pharmaceuticals Co's Dividend Payout Ratio too high?
JCR Pharmaceuticals Co's current Dividend Payout Ratio of 21.00 is 5285% above median its 10-year median of 0.39. Over the past 10 years, this metric has ranged from a low of 0.16 to a high of 5.88. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. JCR Pharmaceuticals Co's value of 21.00 is 5426.3% above this industry median. Based on the distribution chart, JCR Pharmaceuticals Co ranks #443 out of 445 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, JCR Pharmaceuticals Co has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does JCR Pharmaceuticals Co's Dividend Payout Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, JCR Pharmaceuticals Co ranks #443 out of 445 companies for Dividend Payout Ratio. This places JCR Pharmaceuticals Co in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. JCR Pharmaceuticals Co's value of 21.00 is 5426.3% above this benchmark. Historically, JCR Pharmaceuticals Co's own Dividend Payout Ratio has ranged from 0.16 to 5.88 over the past decade. While the company's 10-year median is 0.39 vs. the industry median of 0.38, JCR Pharmaceuticals Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 445 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JCR Pharmaceuticals Co's current Dividend Payout Ratio of 21.00 is 5426.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on JCR Pharmaceuticals Co and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JCR Pharmaceuticals Co's current Dividend Payout Ratio is 21.00, which is 5285% above median its own 10-year median of 0.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JCR Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, JCR Pharmaceuticals Co (JCRRF) is currently considered Possible Value Trap. The stock's GF Value™ is $5.63, compared to a current price of $3.31 — trading 41.2% below its estimated fair value. The current Dividend Payout Ratio is 21.00, which is 5285% above median its 10-year median of 0.39 and 5426.3% above the Drug Manufacturers industry median of 0.38. JCR Pharmaceuticals Co's overall GF Score™ is 55/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For JCR Pharmaceuticals Co (JCRRF), the current Dividend Payout Ratio is 21.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JCR Pharmaceuticals Co (JCRRF) Overvalued in 2026?

Based on GuruFocus' analysis, JCR Pharmaceuticals Co stock appears to be undervalued. The current stock price of $3.31 is trading 41.2% below its estimated GF Value™ of $5.63. GuruFocus considers JCR Pharmaceuticals Co to be Possible Value Trap.

Key valuation signals for JCRRF:

  • Dividend Payout Ratio: 21.00 (5285% above median its 10-year median of 0.39)
  • GF Value™: $5.63 vs. price of $3.31 (41.2% below fair value)
  • GF Score™: 55/100 with 7 warning signs
  • Industry Position: 5426.3% above the Drug Manufacturers median (#443 of 445)

No single metric tells the full story. See the JCRRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JCR Pharmaceuticals Co Business Description

Other Exchanges 4552:Japan
Address 3-19 Kasuga-cho, Ashiya, Hyogo, JPN, 659-0021
JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements.
55GF Score

Get the complete analysis for JCRRF

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.31
Price
$5.63
GF Value